nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—SLCO1A2—Glyburide—gestational diabetes	0.297	0.348	CbGbCtD
Lovastatin—ABCC2—Glyburide—gestational diabetes	0.246	0.288	CbGbCtD
Lovastatin—CYP2C19—Glyburide—gestational diabetes	0.0993	0.117	CbGbCtD
Lovastatin—CYP2C9—Glyburide—gestational diabetes	0.0826	0.0969	CbGbCtD
Lovastatin—ABCB1—Glyburide—gestational diabetes	0.0801	0.094	CbGbCtD
Lovastatin—CYP3A4—Glyburide—gestational diabetes	0.048	0.0563	CbGbCtD
Lovastatin—PON3—islet of Langerhans—gestational diabetes	0.00669	0.132	CbGeAlD
Lovastatin—Jaundice cholestatic—Glyburide—gestational diabetes	0.00486	0.0634	CcSEcCtD
Lovastatin—Vasculitis—Glyburide—gestational diabetes	0.00438	0.0571	CcSEcCtD
Lovastatin—ITGAL—adipose tissue—gestational diabetes	0.00435	0.0861	CbGeAlD
Lovastatin—PON3—adipose tissue—gestational diabetes	0.00427	0.0844	CbGeAlD
Lovastatin—ITGAL—vagina—gestational diabetes	0.00362	0.0715	CbGeAlD
Lovastatin—Hepatic function abnormal—Glyburide—gestational diabetes	0.00355	0.0463	CcSEcCtD
Lovastatin—PON3—vagina—gestational diabetes	0.00355	0.0702	CbGeAlD
Lovastatin—Vascular purpura—Glyburide—gestational diabetes	0.00347	0.0452	CcSEcCtD
Lovastatin—Hepatic failure—Glyburide—gestational diabetes	0.00345	0.045	CcSEcCtD
Lovastatin—Haemolytic anaemia—Glyburide—gestational diabetes	0.00343	0.0448	CcSEcCtD
Lovastatin—Purpura—Glyburide—gestational diabetes	0.00322	0.042	CcSEcCtD
Lovastatin—Arthritis—Glyburide—gestational diabetes	0.00319	0.0416	CcSEcCtD
Lovastatin—HDAC2—islet of Langerhans—gestational diabetes	0.00273	0.0539	CbGeAlD
Lovastatin—Eosinophilia—Glyburide—gestational diabetes	0.00265	0.0346	CcSEcCtD
Lovastatin—HDAC2—embryo—gestational diabetes	0.00264	0.0522	CbGeAlD
Lovastatin—Pancreatitis—Glyburide—gestational diabetes	0.00263	0.0343	CcSEcCtD
Lovastatin—HMGCR—islet of Langerhans—gestational diabetes	0.00246	0.0487	CbGeAlD
Lovastatin—Photosensitivity reaction—Glyburide—gestational diabetes	0.00245	0.0319	CcSEcCtD
Lovastatin—Hepatitis—Glyburide—gestational diabetes	0.00214	0.028	CcSEcCtD
Lovastatin—Alopecia—Glyburide—gestational diabetes	0.0019	0.0247	CcSEcCtD
Lovastatin—HDAC2—uterus—gestational diabetes	0.00178	0.0352	CbGeAlD
Lovastatin—Vision blurred—Glyburide—gestational diabetes	0.00176	0.023	CcSEcCtD
Lovastatin—Tremor—Glyburide—gestational diabetes	0.00175	0.0228	CcSEcCtD
Lovastatin—HDAC2—adipose tissue—gestational diabetes	0.00174	0.0344	CbGeAlD
Lovastatin—Angioedema—Glyburide—gestational diabetes	0.00171	0.0223	CcSEcCtD
Lovastatin—Leukopenia—Glyburide—gestational diabetes	0.00167	0.0218	CcSEcCtD
Lovastatin—HMGCR—uterus—gestational diabetes	0.0016	0.0317	CbGeAlD
Lovastatin—Myalgia—Glyburide—gestational diabetes	0.00159	0.0207	CcSEcCtD
Lovastatin—Arthralgia—Glyburide—gestational diabetes	0.00159	0.0207	CcSEcCtD
Lovastatin—HMGCR—adipose tissue—gestational diabetes	0.00157	0.031	CbGeAlD
Lovastatin—Confusional state—Glyburide—gestational diabetes	0.00154	0.02	CcSEcCtD
Lovastatin—Thrombocytopenia—Glyburide—gestational diabetes	0.00149	0.0195	CcSEcCtD
Lovastatin—Anorexia—Glyburide—gestational diabetes	0.00145	0.019	CcSEcCtD
Lovastatin—HDAC2—vagina—gestational diabetes	0.00145	0.0286	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.00139	0.0181	CcSEcCtD
Lovastatin—Paraesthesia—Glyburide—gestational diabetes	0.00137	0.0179	CcSEcCtD
Lovastatin—Dyspnoea—Glyburide—gestational diabetes	0.00136	0.0177	CcSEcCtD
Lovastatin—Dyspepsia—Glyburide—gestational diabetes	0.00134	0.0175	CcSEcCtD
Lovastatin—HDAC2—head—gestational diabetes	0.00134	0.0264	CbGeAlD
Lovastatin—Decreased appetite—Glyburide—gestational diabetes	0.00132	0.0173	CcSEcCtD
Lovastatin—HMGCR—vagina—gestational diabetes	0.0013	0.0258	CbGeAlD
Lovastatin—Feeling abnormal—Glyburide—gestational diabetes	0.00126	0.0164	CcSEcCtD
Lovastatin—Gastrointestinal pain—Glyburide—gestational diabetes	0.00125	0.0163	CcSEcCtD
Lovastatin—Urticaria—Glyburide—gestational diabetes	0.00121	0.0158	CcSEcCtD
Lovastatin—CYP3A5—islet of Langerhans—gestational diabetes	0.00121	0.0239	CbGeAlD
Lovastatin—HMGCR—head—gestational diabetes	0.00121	0.0238	CbGeAlD
Lovastatin—Abdominal pain—Glyburide—gestational diabetes	0.0012	0.0157	CcSEcCtD
Lovastatin—Hypersensitivity—Glyburide—gestational diabetes	0.00112	0.0146	CcSEcCtD
Lovastatin—Asthenia—Glyburide—gestational diabetes	0.00109	0.0143	CcSEcCtD
Lovastatin—Pruritus—Glyburide—gestational diabetes	0.00108	0.0141	CcSEcCtD
Lovastatin—Diarrhoea—Glyburide—gestational diabetes	0.00104	0.0136	CcSEcCtD
Lovastatin—HMGCR—AMPK Signaling—LEPR—gestational diabetes	0.000989	0.0485	CbGpPWpGaD
Lovastatin—Vomiting—Glyburide—gestational diabetes	0.000969	0.0126	CcSEcCtD
Lovastatin—Rash—Glyburide—gestational diabetes	0.000961	0.0125	CcSEcCtD
Lovastatin—Dermatitis—Glyburide—gestational diabetes	0.00096	0.0125	CcSEcCtD
Lovastatin—UGT1A3—Phase II conjugation—GGCT—gestational diabetes	0.000958	0.0469	CbGpPWpGaD
Lovastatin—Headache—Glyburide—gestational diabetes	0.000955	0.0125	CcSEcCtD
Lovastatin—SLCO1A2—head—gestational diabetes	0.000939	0.0186	CbGeAlD
Lovastatin—Nausea—Glyburide—gestational diabetes	0.000905	0.0118	CcSEcCtD
Lovastatin—UGT2B7—Phase II conjugation—GGCT—gestational diabetes	0.000814	0.0399	CbGpPWpGaD
Lovastatin—CYP2C19—vagina—gestational diabetes	0.000814	0.0161	CbGeAlD
Lovastatin—CYP3A5—adipose tissue—gestational diabetes	0.000771	0.0153	CbGeAlD
Lovastatin—HMGCR—SREBP signalling—RBP4—gestational diabetes	0.000762	0.0374	CbGpPWpGaD
Lovastatin—CYP2C8—vagina—gestational diabetes	0.000711	0.0141	CbGeAlD
Lovastatin—UGT1A1—Phase II conjugation—GGCT—gestational diabetes	0.000662	0.0324	CbGpPWpGaD
Lovastatin—ABCB1—islet of Langerhans—gestational diabetes	0.000643	0.0127	CbGeAlD
Lovastatin—CYP3A5—vagina—gestational diabetes	0.000641	0.0127	CbGeAlD
Lovastatin—ABCB1—embryo—gestational diabetes	0.000621	0.0123	CbGeAlD
Lovastatin—UGT1A3—Biological oxidations—GGCT—gestational diabetes	0.00056	0.0275	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—ADIPOQ—gestational diabetes	0.000559	0.0274	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—GGCT—gestational diabetes	0.000476	0.0234	CbGpPWpGaD
Lovastatin—CYP2D6—head—gestational diabetes	0.000438	0.00865	CbGeAlD
Lovastatin—ABCB1—uterus—gestational diabetes	0.000419	0.00829	CbGeAlD
Lovastatin—ABCB1—adipose tissue—gestational diabetes	0.00041	0.00811	CbGeAlD
Lovastatin—UGT1A1—Biological oxidations—GGCT—gestational diabetes	0.000387	0.019	CbGpPWpGaD
Lovastatin—HMGCR—AMPK Signaling—LEP—gestational diabetes	0.000347	0.017	CbGpPWpGaD
Lovastatin—HDAC2—Regulation of nuclear beta catenin signaling and target gene transcription—AR—gestational diabetes	0.000343	0.0168	CbGpPWpGaD
Lovastatin—ABCB1—vagina—gestational diabetes	0.000341	0.00674	CbGeAlD
Lovastatin—HDAC2—Regulation of nuclear SMAD2/3 signaling—AR—gestational diabetes	0.00034	0.0167	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—GGCT—gestational diabetes	0.000326	0.016	CbGpPWpGaD
Lovastatin—ABCB1—head—gestational diabetes	0.000315	0.00623	CbGeAlD
Lovastatin—HDAC2—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000266	0.013	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—CYP19A1—gestational diabetes	0.000265	0.013	CbGpPWpGaD
Lovastatin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000263	0.0129	CbGpPWpGaD
Lovastatin—CYP3A7—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.00026	0.0127	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—AR—gestational diabetes	0.000258	0.0127	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—GGCT—gestational diabetes	0.000235	0.0115	CbGpPWpGaD
Lovastatin—ITGAL—Extracellular matrix organization—FGF2—gestational diabetes	0.000235	0.0115	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—NAMPT—gestational diabetes	0.000232	0.0114	CbGpPWpGaD
Lovastatin—CYP3A7—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000213	0.0105	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—MBL2—gestational diabetes	0.000209	0.0103	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—GGCT—gestational diabetes	0.000204	0.00999	CbGpPWpGaD
Lovastatin—UGT1A3—Biological oxidations—CYP19A1—gestational diabetes	0.000195	0.00956	CbGpPWpGaD
Lovastatin—UGT1A3—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000192	0.00943	CbGpPWpGaD
Lovastatin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.00019	0.00932	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.00019	0.00932	CbGpPWpGaD
Lovastatin—CYP3A5—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000188	0.0092	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—GGCT—gestational diabetes	0.000182	0.00892	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000182	0.00891	CbGpPWpGaD
Lovastatin—UGT1A3—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000181	0.00888	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—GGCT—gestational diabetes	0.000167	0.0082	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—GGCT—gestational diabetes	0.000166	0.00813	CbGpPWpGaD
Lovastatin—UGT2B7—Biological oxidations—CYP19A1—gestational diabetes	0.000166	0.00813	CbGpPWpGaD
Lovastatin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000165	0.00807	CbGpPWpGaD
Lovastatin—UGT2B7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000163	0.00801	CbGpPWpGaD
Lovastatin—CYP2C8—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000163	0.00797	CbGpPWpGaD
Lovastatin—HDAC2—Neural Crest Differentiation—FGF2—gestational diabetes	0.000156	0.00763	CbGpPWpGaD
Lovastatin—CYP3A5—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000154	0.00756	CbGpPWpGaD
Lovastatin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000147	0.00721	CbGpPWpGaD
Lovastatin—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000145	0.00711	CbGpPWpGaD
Lovastatin—SLCO1A2—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000142	0.00695	CbGpPWpGaD
Lovastatin—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000135	0.00663	CbGpPWpGaD
Lovastatin—UGT1A1—Biological oxidations—CYP19A1—gestational diabetes	0.000135	0.0066	CbGpPWpGaD
Lovastatin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	0.000134	0.00657	CbGpPWpGaD
Lovastatin—CYP2C8—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000134	0.00655	CbGpPWpGaD
Lovastatin—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000133	0.00654	CbGpPWpGaD
Lovastatin—UGT1A1—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000133	0.00651	CbGpPWpGaD
Lovastatin—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	0.000132	0.00649	CbGpPWpGaD
Lovastatin—HDAC2—Signaling events mediated by HDAC Class I—TNF—gestational diabetes	0.000127	0.00623	CbGpPWpGaD
Lovastatin—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—gestational diabetes	0.000125	0.00614	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—GCK—gestational diabetes	0.000121	0.00595	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—FGF2—gestational diabetes	0.000121	0.00591	CbGpPWpGaD
Lovastatin—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000119	0.00584	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—LEP—gestational diabetes	0.000118	0.00579	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GGCT—gestational diabetes	0.000118	0.00576	CbGpPWpGaD
Lovastatin—CYP3A7—Biological oxidations—CYP19A1—gestational diabetes	0.000113	0.00555	CbGpPWpGaD
Lovastatin—CYP3A7—Metapathway biotransformation—CYP19A1—gestational diabetes	0.000112	0.00548	CbGpPWpGaD
Lovastatin—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.00011	0.00537	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GGCT—gestational diabetes	0.000109	0.00536	CbGpPWpGaD
Lovastatin—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	0.000109	0.00536	CbGpPWpGaD
Lovastatin—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	0.000109	0.00533	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GLS2—gestational diabetes	0.000103	0.00504	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GGCT—gestational diabetes	9.58e-05	0.0047	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	9.3e-05	0.00456	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	9.18e-05	0.0045	CbGpPWpGaD
Lovastatin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	8.84e-05	0.00433	CbGpPWpGaD
Lovastatin—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	8.73e-05	0.00428	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GLS2—gestational diabetes	8.38e-05	0.00411	CbGpPWpGaD
Lovastatin—CYP3A5—Biological oxidations—CYP19A1—gestational diabetes	8.19e-05	0.00401	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GGCT—gestational diabetes	8.15e-05	0.00399	CbGpPWpGaD
Lovastatin—CYP3A5—Metapathway biotransformation—CYP19A1—gestational diabetes	8.08e-05	0.00396	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—FGF2—gestational diabetes	7.31e-05	0.00358	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—GCK—gestational diabetes	7.21e-05	0.00353	CbGpPWpGaD
Lovastatin—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	7.17e-05	0.00351	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GLS2—gestational diabetes	7.12e-05	0.00349	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GGCT—gestational diabetes	7.09e-05	0.00348	CbGpPWpGaD
Lovastatin—CYP2C8—Biological oxidations—CYP19A1—gestational diabetes	7.09e-05	0.00348	CbGpPWpGaD
Lovastatin—CYP2C8—Metapathway biotransformation—CYP19A1—gestational diabetes	7e-05	0.00343	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—FGF2—gestational diabetes	6.76e-05	0.00332	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GGCT—gestational diabetes	6.62e-05	0.00325	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—GCK—gestational diabetes	6.56e-05	0.00322	CbGpPWpGaD
Lovastatin—CYP2C19—Biological oxidations—CYP19A1—gestational diabetes	6.33e-05	0.0031	CbGpPWpGaD
Lovastatin—CYP2C19—Metapathway biotransformation—CYP19A1—gestational diabetes	6.24e-05	0.00306	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GLS2—gestational diabetes	6.2e-05	0.00304	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—GCK—gestational diabetes	6.16e-05	0.00302	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GGCT—gestational diabetes	6.07e-05	0.00297	CbGpPWpGaD
Lovastatin—HDAC2—Disease—RBP4—gestational diabetes	5.99e-05	0.00294	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	5.82e-05	0.00285	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GLS2—gestational diabetes	5.79e-05	0.00284	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—CYP19A1—gestational diabetes	5.77e-05	0.00283	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	5.74e-05	0.00282	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—CYP19A1—gestational diabetes	5.69e-05	0.00279	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NAMPT—gestational diabetes	5.63e-05	0.00276	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GCK—gestational diabetes	5.59e-05	0.00274	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GGCT—gestational diabetes	5.57e-05	0.00273	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	5.54e-05	0.00272	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	5.53e-05	0.00271	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LEPR—gestational diabetes	5.45e-05	0.00267	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NAMPT—gestational diabetes	5.37e-05	0.00263	CbGpPWpGaD
Lovastatin—HDAC2—Disease—GCK—gestational diabetes	5.34e-05	0.00262	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GLS2—gestational diabetes	5.3e-05	0.0026	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GLS2—gestational diabetes	4.87e-05	0.00239	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	4.74e-05	0.00232	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NAMPT—gestational diabetes	4.59e-05	0.00225	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GCK—gestational diabetes	4.56e-05	0.00224	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MTNR1B—gestational diabetes	4.31e-05	0.00211	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—RBP4—gestational diabetes	4.2e-05	0.00206	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AR—gestational diabetes	4.09e-05	0.00201	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CYP19A1—gestational diabetes	4.09e-05	0.002	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GGCT—gestational diabetes	4.02e-05	0.00197	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NAMPT—gestational diabetes	3.9e-05	0.00191	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GCK—gestational diabetes	3.88e-05	0.0019	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	3.81e-05	0.00187	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	3.76e-05	0.00184	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—gestational diabetes	3.73e-05	0.00183	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GLS2—gestational diabetes	3.52e-05	0.00172	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GGCT—gestational diabetes	3.49e-05	0.00171	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NAMPT—gestational diabetes	3.4e-05	0.00167	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GCK—gestational diabetes	3.38e-05	0.00166	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP19A1—gestational diabetes	3.33e-05	0.00163	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NAMPT—gestational diabetes	3.17e-05	0.00155	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GCK—gestational diabetes	3.15e-05	0.00154	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GGCT—gestational diabetes	3.11e-05	0.00153	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	3.09e-05	0.00151	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GLS2—gestational diabetes	3.05e-05	0.00149	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GGCT—gestational diabetes	3.04e-05	0.00149	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	3.02e-05	0.00148	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NAMPT—gestational diabetes	2.91e-05	0.00142	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GCK—gestational diabetes	2.89e-05	0.00142	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GGCT—gestational diabetes	2.86e-05	0.0014	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GGCT—gestational diabetes	2.84e-05	0.00139	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP19A1—gestational diabetes	2.84e-05	0.00139	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.72e-05	0.00134	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GLS2—gestational diabetes	2.72e-05	0.00133	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NAMPT—gestational diabetes	2.67e-05	0.00131	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GLS2—gestational diabetes	2.65e-05	0.0013	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GCK—gestational diabetes	2.65e-05	0.0013	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GLS2—gestational diabetes	2.5e-05	0.00123	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GLS2—gestational diabetes	2.48e-05	0.00122	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP19A1—gestational diabetes	2.47e-05	0.00121	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.43e-05	0.00119	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP19A1—gestational diabetes	2.3e-05	0.00113	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.22e-05	0.00109	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP19A1—gestational diabetes	2.11e-05	0.00103	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGF2—gestational diabetes	2.07e-05	0.00102	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP19A1—gestational diabetes	1.94e-05	0.00095	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NAMPT—gestational diabetes	1.93e-05	0.000945	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GCK—gestational diabetes	1.92e-05	0.000939	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LEP—gestational diabetes	1.91e-05	0.000938	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GGCT—gestational diabetes	1.87e-05	0.000917	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	1.84e-05	0.000901	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NAMPT—gestational diabetes	1.67e-05	0.000818	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GCK—gestational diabetes	1.66e-05	0.000813	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GLS2—gestational diabetes	1.64e-05	0.000802	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NAMPT—gestational diabetes	1.49e-05	0.00073	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCK—gestational diabetes	1.48e-05	0.000726	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NAMPT—gestational diabetes	1.45e-05	0.000713	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGF2—gestational diabetes	1.45e-05	0.000712	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCK—gestational diabetes	1.45e-05	0.000709	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP19A1—gestational diabetes	1.4e-05	0.000687	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NAMPT—gestational diabetes	1.37e-05	0.000672	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCK—gestational diabetes	1.36e-05	0.000668	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NAMPT—gestational diabetes	1.36e-05	0.000666	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCK—gestational diabetes	1.35e-05	0.000662	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP19A1—gestational diabetes	1.21e-05	0.000595	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP19A1—gestational diabetes	1.08e-05	0.000531	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP19A1—gestational diabetes	1.06e-05	0.000518	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP19A1—gestational diabetes	9.96e-06	0.000488	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP19A1—gestational diabetes	9.87e-06	0.000484	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NAMPT—gestational diabetes	8.96e-06	0.000439	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCK—gestational diabetes	8.9e-06	0.000437	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP19A1—gestational diabetes	6.51e-06	0.000319	CbGpPWpGaD
